Yun Soo Bae

Goodyear (United Kingdom) — United Kingdom

Immunology and Microbiology · Life Sciences

48h-index13.8kcitations173works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neutrophil, Myeloperoxidase and Oxidative Mechanisms(48), Nitric Oxide and Endothelin Effects(28), Protein Kinase Regulation and GTPase Signaling(18), Neonatal Respiratory Health Research(15), Immune Response and Inflammation(14)

Publications173 total

NADPH Oxidase Inhibition Promotes Brain Resilience by Attenuating Tauopathy and Neuroinflammation in Alzheimer's Disease
Advanced Science·2025· 1 citedOpen Access
A Natural Inhibitor, 1′S-1′-Acetoxychavicol Acetate, Against Testosterone-Induced Alopecia via NADPH Oxidase Regulation
Molecules·2025· 1 citedOpen Access
Phenyl Propanoid 1’s-1′-Acetoxychavicol Acetate Protects Against Testosterone-Induced Alopecia by Inhibiting Nadph Oxidase
Preprints.org·2025Open Access
NADPH oxidase inhibitor enhances brain resilience in Alzheimer’s disease by reducing tauopathy and neuroinflammation
2025Open Access
NADPH oxidase 4-SH3 domain-containing YSC84-like 1 complex participates liver inflammation and fibrosis
Free Radical Biology and Medicine·2024· 1 citedOpen Access
Tanshinone, a Natural NADPH Oxidase Inhibitor, Mitigates Testosterone-Induced Hair Loss
Biomolecules & Therapeutics·2024· 3 citedOpen Access
The desulfinylation enzyme sulfiredoxin-1 attenuates HSC activation and liver fibrosis by modulating the PTPN12-NLRP3 axis
Hepatology·2024· 6 cited
Nox4-SH3YL1 complex is involved in diabetic nephropathy
iScience·2024· 11 citedOpen Access
Ahnak is required to balance calcium ion homeostasis and smooth muscle development in the urinary system
Cell & Bioscience·2023· 6 citedOpen Access
Figure S1 from AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development
2023Open Access
Data from AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development
2023Open Access
Figure S4 from AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development
2023Open Access
Figure S2 from AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development
2023Open Access
Data from AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development
2023Open Access
Figure S4 from AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development
2023Open Access
Figure S3 from AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development
2023Open Access
Figure S1 from AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development
2023Open Access
Supplementary figure legends from AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development
2023Open Access
Figure S3 from AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development
2023Open Access
Figure S5 from AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Sue Goo Rhee(17), Won‐Jae Lee(6), Jung Hee Joo(5), Fujio Sekiya(5), Sang Won Kang(4), Jee Hyun Lee(4), Yury I. Miller(4), In Hye Lee(4), Eun Jung An(4), Sae Rom Lee(4), Sue Goo Rhee(3), Soo Young Lee(3), Hye Sun Park(3), Jaesang Kim(3), Jung-Yeon Yoo(3), Joo‐Heon Yoon(3), Hee Jung Lim(3), Je Kyung Seong(3), Dae Ryong(3), Jaeyul Kwon(2)